Skip to Content
Merck
CN
  • Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth.

Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth.

Cell death and differentiation (2005-11-19)
R A Jones, P Kotsakis, T S Johnson, D Y S Chau, S Ali, G Melino, M Griffin
ABSTRACT

Administration of active TG2 to two different in vitro angiogenesis assays resulted in the accumulation of a complex extracellular matrix (ECM) leading to the suppression of endothelial tube formation without causing cell death. Matrix accumulation was accompanied by a decreased rate of ECM turnover, with increased resistance to matrix metalloproteinase-1. Intratumor injection of TG2 into mice bearing CT26 colon carcinoma tumors demonstrated a reduction in tumor growth, and in some cases tumor regression. In TG2 knockout mice, tumor progression was increased and survival rate reduced compared to wild-type mice. In wild-type mice, an increased presence of TG2 was detectable in the host tissue around the tumor. Analysis of CT26 tumors injected with TG2 revealed fibrotic-like tissue containing increased collagen, TG2-mediated crosslink and reduced organized vasculature. TG2-mediated modulation of cell behavior via changes in the ECM may provide a new approach to solid tumor therapy.